Plant Health Care (GB:PHC) has released an update.
Plant Health Care reported a revenue increase to $11.2 million in 2023, with a significant 72% revenue growth in early 2024, largely due to successful sales in the US market. The company also saw a 153% increase in sales of their novel PREtec peptides, contributing to a steady gross margin of 60%. Operational highlights include strong sales performance in the US and Brazil, and anticipation of strong revenue growth in 2024 backed by new distribution agreements and product registrations.
For further insights into GB:PHC stock, check out TipRanks’ Stock Analysis page.
